Advertisement
Advertisement
GRDN
Guardian Pharmacy Services, Inc.
39.15
USDSponsored
-1.50
-3.68%
Apr 10, 15:59 UTC -4
Closed
After-Market
39.16
+0.01
+0.02%
GRDN Earnings Reports
Positive Surprise Ratio
GRDN beat 2 of 6 last estimates.
33%
Next Report
Date of Next Report
May 11, 2026
Estimate for Q1 26 (Revenue/ EPS)
$336.35M
/$0.23
Implied change from Q4 25 (Revenue/ EPS)
-15.41%
/-30.30%
Implied change from Q1 25 (Revenue/ EPS)
+2.14%
/+53.33%
Guardian Pharmacy Services, Inc. earnings per share and revenue
On Mar 11, 2026, GRDN reported earnings of 0.33 USD per share (EPS) for Q4 25, beating the estimate of 0.25 USD, resulting in a 29.41% surprise. Revenue reached 397.62 million, compared to an expected 396.93 million, with a 0.17% difference. The market reacted with a -0.72% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 6 analysts forecast an EPS of 0.23 USD, with revenue projected to reach 336.35 million USD, implying an decrease of -30.30% EPS, and decrease of -15.41% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Centessa Pharmaceuticals plc - ADR
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.38
Actual
-$0.48
Surprise
-23.58%
Lexeo Therapeutics, Inc. Common Stock
Report Date
Mar 30, 2026 For Q4 25
Estimate
-$0.32
Actual
-$0.27
Surprise
+15.84%
AleAnna, Inc. Class A Common Stock
Report Date
Mar 30, 2026 For Q4 25
Estimate
-Actual
$0.00
Surprise
-
Unicycive Therapeutics, Inc. Common Stock
Report Date
Mar 30, 2026 For Q4 25
Estimate
-$0.48
Actual
-$0.81
Surprise
-69.64%
Galectin Therapeutics Inc.
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.08
Surprise
+21.57%
Cardiol Therapeutics Inc. Class A Common Shares
Report Date
Apr 01, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.07
Surprise
+14.22%
Actinium Pharmaceuticals, Inc
Report Date
Mar 30, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.20
Surprise
-5.04%
Scienture Holdings, Inc. Common Stock
Report Date
Mar 30, 2026 For Q4 25
Estimate
-$0.28
Actual
-$0.11
Surprise
+61.48%
Jupiter Neurosciences, Inc. Common Stock
Report Date
Apr 01, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.06
Surprise
+6.16%
Reviva Pharmaceuticals Holdings, Inc. Common Stock
Report Date
Mar 30, 2026 For Q4 25
Estimate
-$1.19
Actual
-Surprise
-
FAQ
What were Guardian Pharmacy Services, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Guardian Pharmacy Services, Inc. reported EPS of $0.33, beating estimates by 29.41%, and revenue of $397.62M, 0.17% above expectations.
How did the market react to Guardian Pharmacy Services, Inc.'s Q4 2025 earnings?
The stock price moved down -0.72%, changed from $33.51 before the earnings release to $33.27 the day after.
When is Guardian Pharmacy Services, Inc. expected to report next?
The next earning report is scheduled for May 11, 2026.
What are the forecasts for Guardian Pharmacy Services, Inc.'s next earnings report?
Based on 6
analysts, Guardian Pharmacy Services, Inc. is expected to report EPS of $0.23 and revenue of $336.35M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement